Turkish company to buy anti-cancer drugs from Bangladesh
1:12 pm, October 04, 2016
Bangladeshi pharmaceuticals company Beacon Pharmaceuticals Ltd, which is specialised in oncology medicines, and Turkish pharmaceuticals producer and distribution company Kare Ilac on Monday signed a contract at Bangladesh Embassy in Ankara on Monday.
The agreement was signed by the senior officials of the two sides in the presence of Bangladesh Ambassador to Turkey, M. Allama Siddiki,
Under the contract, the Turkish company agreed to import, distribute and market in Turkey the anti-cancer, biotech and lifesaving drugs of Beacon pharmaceuticals.
It is expected that successful implementation of the agreement between the Turkish and the Bangladeshi companies would contribute to a large extent in enhancing the export of pharmaceuticals products to Turkey, according to a message received here from Bangladesh mission in Ankara.
Aanother Turkish Company, Koc Ilac, is currently importing in Turkey some pharmaceuticals products of Incepta Pharmaceuticals of Bangladesh since 2014.
Other news Of this category
- 3 African countries to get 1st malaria vaccine
- Is it safe or not to drink water after eating watermelon?
- Australian scientists halt growth of colon, stomach cancers
- Child TB patients in Bangladesh rising
- Girl with ‘Treeman’ syndrome went under successful surgery